Synaptotagmin: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
<StructureSection load=' | <StructureSection load='4npk' size='340' side='right' caption='Caption for this structure' scene=''> | ||
== Function == | == Function == | ||
| Line 9: | Line 9: | ||
== Relevance == | == Relevance == | ||
'''Synaptotagmin-4''' is up-regulated by chronic depolarization and seizures. '''Synaptotagmin-1''' is promising biomarker to monitor dysfunction and degeneration in Alzheimer disease<ref>PMID:27716408</ref>. | '''Synaptotagmin-4''' is up-regulated by chronic depolarization and seizures. '''Synaptotagmin-1''' is a promising biomarker to monitor dysfunction and degeneration in Alzheimer disease<ref>PMID:27716408</ref>. | ||
== Structural highlights == | == Structural highlights == | ||